People: Idenix Pharmaceuticals Inc (IDIX.O)
4.17USD
17 May 2013
$0.27 (+6.92%)
$3.90
$3.90
$4.19
$3.81
3,052,935
893,663
$11.30
$3.21
Wyzga, Michael
Brief Biography
Mr. Michael S. Wyzga is Independent Director of Idenix Pharmaceuticals Inc., since March 01, 2012. Mr. Wyzga has served since December 2011 as the president and chief executive officer and as a member of the board of directors of Radius Health, Inc., a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women’s health conditions. Prior to that, Mr. Wyzga served in various senior management positions at Genzyme Corporation, a global biotechnology company. Mr. Wyzga joined Genzyme in February 1998 and most recently served as executive vice president, finance from May 2003 until November 2011 and as chief financial officer from July 1999 until November 2011. Mr. Wyzga received a B.S. from Suffolk University and an M.B.A. from Providence College.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Thomas Hodgson |
-- |
Ronald Renaud |
1,383,760 |
Daniella Beckman |
501,542 |
David Standring |
738,193 |
Douglas Mayers |
680,578 |
Maria Stahl |
573,723 |

